Differentiation of malignant and benign cardiac tumors using 18F-FDG PET/CT

Journal of Nuclear Medicine

Volumn 53, Issue 6, 2012, Pages 856-863

  Rahbar, Kambiz ^a   Seifarth, Harald ^a   Schäfers, Michael ^a   Stegger, Lars ^a   Hoffmeier, Andreas ^a   Spieker, Tilmann ^a   Tiemann, Klaus ^a   Maintz, David ^a   Scheld, Hans Heinrich ^a   Schober, Otmar ^a   Weckesser, Matthias ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

18F FDG PET CT; Cardiac angiosarcoma; Cardiac metastases; Cardiac tumors

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ANGIOSARCOMA; ARTICLE; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FIBROELASTOMA; FIBROMA; HEART METASTASIS; HEART MYXOMA; HEART TUMOR; HEMANGIOMA; HEMATOMA; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LIPOSARCOMA; MALE; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIMARY TUMOR; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION; WHOLE BODY IMAGING;

ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HEART NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY;

EID: 84861913773     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.111.095364     Document Type: Article

References (37)

1. Burke A, Virmani S. Atlas of Tumor Pathology. Washington, DC: Washington-Armed Force Institute of Tumor Pathology; 1996.
2. Reynen K. Cardiac myxomas. N Engl J Med. 1995;333:1610-1617.
3. Bussani R, De-Giorgio F, Abbate A, Silvestri F. Cardiac metastases. J Clin Pathol. 2007;60:27-34. (Pubitemid 46142668)
4. Chiles C, Woodard PK, Gutierrez FR, Link KM. Metastatic involvement of the heart and pericardium: CT and MR imaging. Radiographics. 2001;21:439-449. (Pubitemid 33707769)
5. Hoey ET, Mankad K, Puppala S, Gopalan D, Sivananthan MU. MRI and CT appearances of cardiac tumours in adults. Clin Radiol. 2009;64:1214-1230.
6. Araoz PA, Eklund HE, Welch TJ, Breen JF. CT and MR imaging of primary cardiac malignancies. Radiographics. 1999;19:1421-1434.
7. Castillo JG, Silvay G. Characterization and management of cardiac tumors. Semin Cardiothorac Vasc Anesth. 2010;14:6-20.
8. Hoffmann U, Globits S, Schima W, et al. Usefulness of magnetic resonance imaging of cardiac and paracardiac masses. Am J Cardiol. 2003;92:890-895. (Pubitemid 37163597)
9. Araoz PA, Mulvagh SL, Tazelaar HD, Julsrud PR, Breen JF. CT and MR imaging of benign primary cardiac neoplasms with echocardiographic correlation. Radiographics. 2000;20:1303-1319.
10. Weber WA. Assessing tumor response to therapy. J Nucl Med. 2009;50(suppl 1):1S-10S.
11. Weber WA. Positron emission tomography as an imaging biomarker. J Clin Oncol. 2006;24:3282-3292. (Pubitemid 46622068)
12. Agostini D, Babatasi G, Galateau F, Grollier G, Potier JC, Bouvard G. Detection of cardiac myxoma by F-18 FDG PET. Clin Nucl Med. 1999;24:159-160. (Pubitemid 29094268)
13. Freudenberg LS, Rosenbaum SJ, Schulte-Herbruggen J, et al. Diagnosis of a cardiac angiosarcoma by fluorine-18 fluordeoxyglucose positron emission tomography. Eur Radiol. 2002;12(suppl 3):S158-S161. (Pubitemid 40826287)
14. Higashiyama S, Kawabe J, Hayashi T, et al. Effectiveness of preoperative PET examination of huge angiosarcoma of the heart. Clin Nucl Med. 2009;34:99-102.
15. Hoffmeier A, Etz C, Schmid C, et al. Images in cardiovascular medicine: cardiac transplantation for giant sarcoma of the left ventricle. Circulation. 2005;112:e247-e249.
16. Hori Y, Funabashi N, Miyauchi H, et al. Angiosarcoma in the right atria demonstrated by fusion images of multislice computed tomography and positron emission tomography using F-18 fluoro-deoxyglucose. Int J Cardiol. 2007;123:e15-e17. (Pubitemid 350116969)
17. Nakamura-Horigome M, Koyama J, Eizawa T, et al. Successful treatment of primary cardiac angiosarcoma with docetaxel and radiotherapy. Angiology. 2008;59:368-371. (Pubitemid 351793163)
18. Orcurto MV, Delaloye AB, Letovanec I, Martins Favre M, Prior JO. Detection of an asymptomatic right-ventricle cardiac metastasis from a small-cell lung cancer by F-18-FDG PET/CT. J Thorac Oncol. 2009;4:127-130.
19. Plutchok JJ, Boxt LM, Weinberger J, Fawwaz R, Sherman WH, Van Heertum RL. Differentiation of cardiac tumor from thrombus by combined MRI and F-18 FDG PET imaging. Clin Nucl Med. 1998;23:324-325. (Pubitemid 28201739)
20. Schnabel R, Koniordos P, Mohr-Kahaly S, Meyer J, Kohler HH, Khaw AV. Primary adenocarcinoma of the left atrium mimicking benign myxoma. Z Kardiol. 2003;92:254-259. (Pubitemid 36398941)
21. Shimotsu Y, Ishida Y, Fukuchi K, et al. Fluorine-18-fluorodeoxyglucose PET identification of cardiac metastasis arising from uterine cervical carcinoma. J Nucl Med. 1998;39:2084-2087. (Pubitemid 29001794)
22. Zhang M, Li B, Jiang X. PET/CT imaging in a case of cardiac liposarcoma. J Nucl Cardiol. 2008;15:473-475.
23. Biancheri I, Zsigmond R, Angoue O, et al. F-18 FDG PET identification of right atrium metastasis from a vesical carcinoma. Clin Nucl Med. 2007;32:812-815. (Pubitemid 47476353)
24. Nonaka A, Stugaard M, Ueda O, Hara H, Shimada T, Shiotani H. Fluorodeoxy-glucose-positron emission tomography differentiating thrombus from tumor in the left ventricle. J Am Coll Cardiol. 2009;53:894.
25. Wenning C, Engelen MA, Rahbar K, et al. Therapy refractory coronary compression caused by a cardiac metastasis: the role of imaging. J Nucl Cardiol. 2010;17:696-698.
26. Juergens KU, Oei ML, Weckesser M, et al. Whole-body imaging of oncologic patients using 16-channel PET-CT: evaluation of an i.v. contrast enhanced MDCT protocol. Nuklearmedizin. 2008;47:30-36. (Pubitemid 351272808)
27. Weckesser M, Stegger L, Juergens KU, Wormanns D, Heindel W, Schober O. Correlation between respiration-induced thoracic expansion and a shift of central structures. Eur Radiol. 2006;16:1614-1620. (Pubitemid 43871835)
28. 18F-FDG PET in oncology. J Nucl Med. 2008;49:480-508.
29. Weber WA, Avril N, Schwaiger M. Relevance of positron emission tomography (PET) in oncology. Strahlenther Onkol. 1999;175:356-373. (Pubitemid 29393147)
30. Fischman AJ. Positron emission tomography in the clinical evaluation of metastatic cancer. J Clin Oncol. 1996;14:691-696. (Pubitemid 26085511)
31. Benz MR, Czernin J, Allen-Auerbach MS, et al. FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas. Clin Cancer Res. 2009;15:2856-2863.
32. Reske SN, Bares R, Bull U, Guhlmann A, Moser E, Wannenmacher MF. Clinical value of positron emission tomography (PET) in oncologic questions: results of an interdisciplinary consensus conference. Schirmerreschaft der Deutschen Gesellschaft for Nuklearmedizin. Nuklearmedizin. 1996;35:42-52. (Pubitemid 26116272)
33. Reske SN, Kotzerke J. FDG-PET for clinical use: results of the 3rd German interdisciplinary consensus conference, "Onko-PET III", 21 July and 19 September 2000. Eur J Nucl Med. 2001;28:1707-1723. (Pubitemid 33036116)
34. Krombach GA, Spuentrup E, Buecker A, et al. Heart tumors: magnetic resonance imaging and multislice spiral CT. Rofo. 2005;177:1205-1218. (Pubitemid 41290816)
35. Grebenc ML, Rosado de Christenson ML, Burke AP, Green CE, Galvin JR. Primary cardiac and pericardial neoplasms: radiologic-pathologic correlation. Radiographics. 2000;20:1073-1103; quiz 1110-1111, 1112.
36. Büther F, Stegger L, Dawood M, et al. Effective methods to correct contrast agent-induced errors in PET quantification in cardiac PET/CT. J Nucl Med. 2007;48:1060-1068. (Pubitemid 47052643)
37. Dawood M, Kosters T, Fieseler M, et al. Motion correction in respiratory gated cardiac PET/CT using multi-scale optical flow. Med Image Comput Comput Assist Interv. 2008;11:155-162.